This post originally appeared on Fast Data Science’s blog on LinkedIn.
Budgeting for clinical trials is crucial to ensure all study aspects are covered and adequately funded. The process involves detailed planning, considering the scope of the work, and addressing specific trial needs, such as personnel, procedures, and participant-related costs.
Personnel Costs:
Study Procedures:
Protocol-Related Fees:
Travel, Meetings, and Miscellaneous Costs:
Overall Budget: The Principal Investigator (PI) manages the entire budget for multi-site or single-site trials.
Site Budget: When the local PI negotiates the site-specific budget, including patient enrollment and closeout costs.
Define the Clinical Question:
Determine Per-Subject Costs:
Identify Ancillary Department Costs:
Estimate Personnel Costs:
Include Protocol-Related Fees:
Account for Hidden Costs:
Minimize Data Collection: Collect only necessary data points to reduce costs.
Don’t Underestimate Recruitment Time: Failing to recruit patients on schedule can increase costs as infrastructure expenses grow.
Pay for Specific Tasks: Instead of budgeting for full-time equivalents (FTE), pay for time spent on tasks.
Needs to be more accurate in the number of patients or the time required to complete the study.
Overlooking hidden costs, such as adverse events or additional patient monitoring.
Forgetting to budget for specific storage, audit, and protocol amendment fees.
Upload your first clinical protocol for FREE. 👈
Creating a clinical trial budget involves careful planning, considering all possible costs, and aligning the budget with the trial’s scope. By focusing on essential tasks, minimizing unnecessary procedures, and allowing flexibility for unexpected costs, you can create a comprehensive and effective budget to keep your clinical trial on track.
References:
NIH Clinical Trial Budgeting https://www.nihstrokenet.org/
Guest post by Youssef Soliman, medical student at Assiut University and biostatistician Designing a high-quality clinical trial protocol is critical for the success of any study. A protocol is the blueprint that outlines every aspect of a trial. In an ideal world, a flawless protocol would require no revisions and include only essential elements. In reality, however, the average protocol undergoes 2–3 amendments and often contains excessive data collection and overly complex entry criteria.
Clinical trials have long been the foundation of medical breakthroughs, but traditional methods often stumble over slow timelines, high costs, and difficulties in finding the right participants. Artificial intelligence (AI) — a technology ready to transform this landscape by making trials faster, more affordable, and smarter. The accelerating adoption of AI in clinical trials signals a major shift in healthcare research. It is already making significant strides in transforming clinical trials.
Guest post by Safeer Khan, Lecturer at Department of Pharmaceutical Sciences, Government College University, Lahore, Pakistan In clinical trials, a staggering 80% encounter delays during the startup phase and 37% struggle to meet enrollment targets. Read more Key clinical trial statistics. These figures highlight a critical, yet often underemphasized, aspect of clinical trials—the feasibility process. The feasibility process is essential for assessing the practicality of a clinical trial’s design, ensuring the study is prepared to tackle the challenges that may arise.
